NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
Clinical trials for NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) explained in plain language.
Never miss a new study
Get alerted when new NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) trials appear
Sign up with your email to follow new studies for NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a promising NAFLD drug safely mix with other medicines? a trial seeks answers
Disease control Not yet recruitingThis trial investigates whether ECC4703, a potential new treatment for non-alcoholic fatty liver disease (NAFLD), changes how the body processes two other drugs: sulfasalazine and pitavastatin. Healthy adults aged 18 to 65 will take these drugs alone and then with ECC4703 to meas…
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
Phase: PHASE1 • Sponsor: Eccogene • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Diabetes drug takes on statins in battle against fatty liver
Disease control Not yet recruitingThis study tests whether empagliflozin (a diabetes drug) works better than statins for treating non-alcoholic fatty liver disease (NAFLD) and its more severe form, NASH. 400 obese, diabetic adults with NAFLD/NASH will take one of five drug combinations daily for 3 months. Researc…
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
Phase: PHASE4 • Sponsor: Badr University • Aim: Disease control
Last updated Jun 26, 2026 17:53 UTC